AI assistant
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2012
Nov 30, 2012
29977_dirs_2012-11-30_4995d0f3-0373-4bfe-9a27-bd9483dd6538.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS INC (REGN)
CIK: 0000872589
Period of Report: 2012-11-28
Reporting Person: VAGELOS P ROY (Director, Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-28 | Common Stock | S | 7004.0 | $175.03 | Disposed | 135576.0 | Direct |
| 2012-11-29 | Common Stock | S | 1800.0 | $175.95 | Disposed | 133776.0 | Direct |
| 2012-11-29 | Common Stock | S | 5100.0 | $176.54 | Disposed | 128676.0 | Direct |
| 2012-11-29 | Common Stock | S | 4402.0 | $177.09 | Disposed | 124274.0 | Direct |
| 2012-11-29 | Common Stock | S | 18440.0 | $178.71 | Disposed | 105834.0 | Direct |
| 2012-11-29 | Common Stock | S | 19733.0 | $179.6 | Disposed | 86101.0 | Direct |
| 2012-11-29 | Common Stock | S | 12000.0 | $180.59 | Disposed | 74101.0 | Direct |
| 2012-11-29 | Common Stock | S | 17155.0 | $181.19 | Disposed | 56946.0 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 82410.0 | Indirect |
| Common Stock | 2329.0 | Indirect |
| Common Stock | 162657.0 | Indirect |
| Common Stock | 15162.0 | Indirect |
| Common Stock | 3.0 | Indirect |
| Common Stock | 127500.0 | Indirect |
| Common Stock | 1203.0 | Indirect |
Footnotes
F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2: Represents volume-weighted average price of sales of 7,004 shares of Company stock on November 28, 2012 at prices ranging from $175.00 to $175.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 28, 2012 at each separate price.
F3: Represents volume-weighted average price of sales of 1,800 shares of Company stock on November 29, 2012 at prices ranging from $175.45 to $175.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
F4: Represents volume-weighted average price of sales of 5,100 shares of Company stock on November 29, 2012 at prices ranging from $176.00 to $176.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
F5: Represents volume-weighted average price of sales of 4,402 shares of Company stock on November 29, 2012 at prices ranging from $177.00 to $177.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
F6: Represents volume-weighted average price of sales of 18,440 shares of Company stock on November 29, 2012 at prices ranging from $178.51 to $178.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
F7: Represents volume-weighted average price of sales of 19,733 shares of Company stock on November 29, 2012 at prices ranging from $179.00 to $179.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
F8: Represents volume-weighted average price of sales of 12,000 shares of Company stock on November 29, 2012 at prices ranging from $180.00 to $180.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
F9: Represents volume-weighted average price of sales of 17,155 shares of Company stock on November 29, 2012 at prices ranging from $181.00 to $181.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
F10: By an irrevocable trust for the benefit of grandchildren of the reporting person, of which the spouse of the reporting person is trustee.
F11: By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.